2025年美国心脏协会《科学声明:先天性心脏病患者全生命周期的心肺运动试验》解读OA

The decline in exercise tolerance and complications such as arrhythmias caused by long-term impairment of cardiopulmonary function significantly affect the quality of life and prognosis of patients with congenital heart disease(CHD).Cardiopulmonary exercise testing(CPET)provides objective evidence for functional assessment,risk stratification,and clinical intervention in CHD patients,thus constituting an essential part of lifelong care for them.However,due to the anatomical heterogeneity of CHD and physiological changes related to patient age,the clinical interpretation of CPET parameters faces substantial challenges.In 2025,the American Heart Association(AHA)published the"Scientific Statement:Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Patients with Congenital Heart Disease",which systematically summarizes typical CPET parameter variations of different types of CHD and their clinical significance.This paper aims to interpret the AHA statement,aiming to provide more comprehensive theoretical support and practical guidance for clinicians and healthcare providers,and thus enhance clinical management level and improve the quality of life of patients with CHD.